Studies have not investigated the range of BRAF mutations, co-occurring alterations, and their clinical implications across a large set of sequenced genes, nor have there been robust comparisons of BRAF alteration types between adult and pediatric gliomas. This evidence concerns the gene BRAF and glioma.